ArticleEmerging infectious diseases2010
Multidrug-resistant Salmonella enterica serovar Infantis, Israel.
Article in Emerging infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- Novel pESI-encoded autotransporter adhesin PeaP of epidemicbioRxiv : the preprint server for biology · 2026Article
- Cardiac Device-Related Infective Endocarditis Caused byPathogens (Basel, Switzerland) · 2025Review
- Genomic characterisation of the population structure and antibiotic resistance ofLancet regional health. Americas · 2024Article
- Effects ofMicroorganisms · 2023Article
- Geographical and temporal distribution of multidrug-resistantFrontiers in microbiology · 2023Article
- Genomic Analysis of Two MDR Isolates ofAntibiotics (Basel, Switzerland) · 2022Article
- What makes a megaplasmid?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022Article
- Infection dynamics ofEmerging microbes & infections · 2021Article
- Characterization of a pESI-like plasmid and analysis of multidrug-resistantMicrobial genomics · 2021Article
- Comparative Genomics of Emerging Lineages and Mobile Resistomes of Contemporary Broiler Strains ofFrontiers in microbiology · 2021Article
- Genetic Profiles and Antimicrobial Resistance Patterns ofAntibiotics (Basel, Switzerland) · 2020Article
- Characterization of non-typhoidal Salmonella isolates from children with acute gastroenteritis, Kolkata, India, during 2000-2016.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2020Article
- Genome Sequence of an Emerging Salmonella enterica Serovar Infantis and Genomic Comparison with Other S. Infantis Strains.Genome biology and evolution · 2020Article
- Comparative Genome Analysis of Hungarian and Global Strains ofFrontiers in microbiology · 2020Article
- Article
- Persistent Infection and Long-Term Carriage of Typhoidal and Nontyphoidal Salmonellae.Clinical microbiology reviews · 2019Review
- Article
- Comparative Genomics and Phenotypic Investigations Into Antibiotic, Heavy Metal, and Disinfectant Susceptibilities ofFrontiers in microbiology · 2019Article
- Distribution of extended-spectrum β-lactamases (ESBLs) amongIranian journal of microbiology · 2018Article
- A novel prophage identified in strains from Salmonella enterica serovar Enteritidis is a phylogenetic signature of the lineage ST-1974.Microbial genomics · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To determine whether rapid emergence of Salmonella enterica serovar Infantis in Israel resulted from an increase in different biotypes or spread of 1 clone, we characterized 87 serovar Infantis isolates on the genotypic and phenotypic levels. The emerging strain comprised 1 genetic clone with a distinct pulsed-field gel electrophoresis profile and a common antimicrobial drug resistance pattern.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.